ReviewArchives of toxicology2026
Scorpion venom as a molecular treasure: emerging bioactive compounds and translational therapeutic insights.
Review in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Scorpion Venom Peptides: From Structural Scaffolds to Therapeutic Applications-A Focus on Antioxidant Mechanisms and Translational Perspectives.Antioxidants (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Scorpion venom contains a diverse array of bioactive compounds, including peptides, proteins, enzymes, and alkaloids, which hold significant medicinal potential despite their toxicity due to interactions with voltage-gated sodium, potassium, and calcium channels affecting the autonomic nervous system. A comprehensive study analyzing literature from esteemed scientific databases (2000-2025) evaluates the structural and functional properties of these venom components. Enzymes and proteins exhibit anticancer properties through apoptosis induction, angiogenesis inhibition, and immune modulation, while ion channel modulators show promise in treating neurological disorders, pain, and cardiac arrhythmias. Antimicrobial peptides demonstrate high efficacy against multidrug-resistant (MDR) bacteria. Certain alkaloids also offer antioxidant and immunoregulatory benefits. A pioneering study on advanced nano-systems derived from scorpion venom has highlighted their potential to enhance drug delivery and therapeutic efficacy. Translational promise is further supported by advancements in recombinant expression, structure-activity relationship investigations, and innovative delivery strategies, despite challenges such as toxicity and stability. Scorpion venom thus represents a rich source of compounds with significant medicinal and biological applications.
Indexed as
Identifiers
41361124What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.